Abbott Labs (ABT) China Pediatric Nutrition Sales Less Than $500M

Go back to Abbott Labs (ABT) China Pediatric Nutrition Sales Less Than $500M

Goldman Sachs Downgrades Mead Johnson Nutrition (MJN) to Neutral

July 3, 2013 9:43 AM EDT

Goldman Sachs downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Neutral.

For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.

Shares of Mead Johnson Nutrition closed at $74.90 yesterday, with a 52 week range of $61.27-$86.87.... More

Wells Fargo Cuts Mead Johnson Nutrition (MJN) to Market Perform

July 3, 2013 8:37 AM EDT

Wells Fargo downgraded Mead Johnson Nutrition (NYSE: MJN) from Outperform to Market Perform with a price target of $77.00 (from $88.00).

Analyst John Baumgartner said, "First, is 7/2s news China will be investigating formula market leaders for price fixing and antitrust issues. Second, weakening GDP growth in... More

UPDATE: Mead Johnson (MJN) Cooperating with China in Antitrust Investigation

July 2, 2013 2:18 PM EDT

(Updated - July 2, 2013 2:26 PM EDT)

Shares of Mead Johnson Nutrition (NYSE: MJN) declined on Tuesday. The decline follows reports that it and Abbott Laboratories (NYSE: ABT) are among five foreign infant milk companies under investigation in China for possible antitrust violations.

In response, Mead Johnson Nutrition announced today that it is committed to providing high-quality and safe products at a good... More